New research shows that dialing down an overactive immune sensor can restore tissue health in severe genetic disorders, reshaping how scientists think about aging and DNA damage.
The human immune system is finely tuned to detect and destroy viral threats. But this same defense system can misfire. When fragments of the body’s own damaged DNA are mistaken for viral invaders, the result is a powerful, misplaced inflammatory response that harms the body it is meant to protect.
Now, an international team led by Dr. Marva Bergman and Prof. Itamar Harel at Hebrew University, in collaboration with Prof. Yehuda Tzfati, Prof. Ido Ben-Ami (Hebrew University and Sha’are Zedek Medical Center), and Prof. Bérénice Benayoun (University of Southern California), has identified this misdirected immune response as a central driver of tissue degeneration in severe, rapid-aging disorders. By reducing this false alarm, the researchers were able to restore function across multiple biological systems.
The findings focus on rare DNA damage-repair (DDR) syndromes such as Ataxia-Telangiectasia (A-T) and Bloom syndrome. In these conditions, the machinery that normally repairs everyday DNA damage is impaired, leading to widespread genomic instability, neurodegeneration, cancer susceptibility, and premature aging.
For decades, scientists believed that the accumulation of unrepaired DNA was itself the primary cause of cellular decline. This study challenges that view.
“Our results show that the damage isn’t acting alone,” said Prof. Harel. “It’s the body’s response to that damage, an exaggerated, chronic inflammatory reaction, that drives much of the degeneration.”
When DNA repair fails, fragments of DNA can leak into the cell’s cytosol, where they activate a molecular sensor known as cGAS. This pathway typically detects viral DNA, but it cannot reliably distinguish between foreign and self-derived fragments. The result is a sustained, sterile inflammatory response that damages tissues.
The researchers also uncovered a second, unexpected role for cGAS. Beyond triggering inflammation, it can enter the cell nucleus and directly interfere with DNA repair processes. This dual function makes it both a protector under normal conditions and a potent driver of damage when the system is overwhelmed.
To test whether moderating this response could alter disease progression, the team used a fast-aging vertebrate model that allows rapid evaluation of aging-related processes. When cGAS activity was reduced in this system, key disease features, including neuroinflammation, tissue degeneration, and loss of reproductive capacity, were substantially improved.
“We weren’t just slowing decline,” said Dr. Bergman. “We saw broad restoration of tissue function. It suggests that the body can cope with more DNA damage than we assumed, if the inflammatory response is kept in check.”
The implications for treatment are significant. Rather than attempting to repair every DNA lesion, therapies could focus on modulating how the body responds to damage. However, the researchers caution that cGAS also plays a critical role in antiviral defense, meaning that future therapies will need to selectively dampen harmful activity without compromising immunity.
Beyond rare genetic disorders, the findings may have broader relevance for age-related diseases, where chronic inflammation and genomic instability often coexist.
Complementary studies from the group further highlight how fundamental biological programs, such as reproduction and developmental timing, intersect with aging and lifespan. Together, this work points to a unifying idea: the same systems that support early-life fitness may also shape the limits of long-term health.
Importantly, the researchers note that reversing severe disease processes is not the same as slowing the intrinsic pace of aging. Still, by identifying how the body’s own alarm systems contribute to decline, this study opens a promising new direction for treating some of the most challenging degenerative conditions.